Infectious Disease & Vaccines
Part of Biotech - Drug Development
 MRK | Merck & Co., Inc. | $317.4b | $127.58 | +0.0% | 10.7M |
 GILD | Gilead Sciences Inc | $156.9b | $134.40 | -1.5% | 5.1M |
 PFE | Pfizer Inc. | $137.2b | $25.07 | -0.3% | 33.4M |
 MRNA | Moderna, Inc. Common Stock | $27.8b | $61.87 | -2.1% | 3.9M |
 SMMT | Summit Therapeutics Inc. Common Stock | $11.3b | $13.92 | +0.4% | 2.5M |
 PCVX | Vaxcyte, Inc. Common Stock | $8.4b | $56.27 | +0.3% | 830.3K |
 BCRX | BioCryst Pharmaceuticals Inc | $2.5b | $9.28 | +2.0% | 2.8M |
 VIR | Vir Biotechnology, Inc. Common Stock | $1.7b | $9.52 | +0.4% | 1.5M |
 NVAX | Novavax Inc | $1.5b | $8.19 | -0.4% | 1.9M |
 ABUS | Arbutus Biopharma Corporation Common Stock | $0.9b | $4.55 | -3.8% | 1.4M |
 CRMD | CorMedix Inc. | $0.6b | $8.39 | +1.4% | 603.1K |
 ASMB | Assembly Biosciences, Inc | $0.5b | $26.76 | +3.8% | 287.6K |
 EBS | Emergent Biosolutions, Inc. | $432.4m | $7.81 | -0.8% | 516.3K |
 ENTA | Enanta Pharmaceuticals, Inc | $424.0m | $13.74 | +4.2% | 152.3K |
 AVIR | Atea Pharmaceuticals, Inc. Common Stock | $372.1m | $4.82 | +3.5% | 171.3K |
 SIGA | SIGA Technologies Inc. | $261.1m | $3.52 | -3.1% | 297.2K |
 IVVD | Invivyd, Inc. Common Stock | $257.0m | $0.75 | -5.7% | 1.9M |
 ARMP | Armata Pharmaceuticals, Inc. Common Stock | $237.9m | $4.27 | +14.8% | 256.0K |
 TNXP | Tonix Pharmaceuticals Holding Corp. | $203.4m | $12.38 | +4.4% | 669.5K |
 ARCT | Arcturus Therapeutics Holdings Inc. Common Stock | $191.0m | $6.04 | -1.9% | 365.3K |
 ANTX | AN2 Therapeutics, Inc. Common Stock | $174.3m | $4.67 | +0.4% | 50.8K |
 SPRO | Spero Therapeutics, Inc. Common Stock | $128.0m | $1.59 | +0.6% | 1.2M |
 INO | Inovio Pharmaceuticals, Inc. | $90.5m | $1.13 | 0.0% | 806.0K |
 MCRB | Seres Therapeutics, Inc. | $76.4m | $5.55 | +2.1% | 55.5K |
 XBIT | XBiotech Inc | $70.1m | $2.30 | -0.4% | 58.6K |
 ZTEK | Zentek Ltd. Common Stock | $59.3m | $0.50 | 0.0% | 83.2K |
 IBO | Impact BioMedical, Inc. | $49.6m | $0.45 | -3.5% | 16.2K |
 SCYX | SCYNEXIS, Inc. | $40.4m | $4.29 | -4.7% | 21.7K |
 ALGS | Aligos Therapeutics, Inc. Common Stock | $35.7m | $5.73 | -0.7% | 45.5K |
 NNVC | NanoViricides Inc. | $31.7m | $1.75 | -2.3% | 173.6K |
 PLRZ | Polyrizon Ltd. Ordinary Shares | $26.1m | $13.38 | +0.9% | 7.9K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $23.9m | $4.18 | 0.0% | 7.3K |
 ATOS | Atossa Therapeutics, Inc. Common Stock | $19.3m | $2.44 | +4.6% | 47.0K |
 MBRX | Moleculin Biotech, Inc. | $14.9m | $2.11 | -2.8% | 148.6K |
 COCP | Cocrystal Pharma, Inc. Common Stock | $14.5m | $0.96 | +0.7% | 10.3K |
 TRAW | Traws Pharma, Inc. Common Stock | $12.8m | $0.70 | +2.2% | 50.0K |
 CODX | Co-Diagnostics, Inc. Common Stock | $11.4m | $2.44 | -1.4% | 64.2K |
 AIM | AIM ImmunoTech Inc. | $7.9m | $0.26 | -5.9% | 471.9K |
 IMNN | Imunon, Inc. Common Stock | $7.5m | $1.84 | -4.2% | 28.3K |
 XBIO | Xenetic Biosciences, Inc. | $6.7m | $2.89 | 0.0% | 13.8K |
 ACXP | Acurx Pharmaceuticals, Inc. Common Stock | $6.7m | $1.55 | 0.0% | 31.7K |
 GOVX | GeoVax Labs, Inc. New | $6.6m | $0.96 | +13.2% | 324.4K |
 APM | Aptorum Group Limited Class A Ordinary Shares | $6.4m | $0.67 | +2.2% | 163.9K |
 SNGX | Soligenix, Inc. Common Stock | $5.9m | $0.36 | -1.3% | 633.5K |
 SXTP | 60 Degrees Pharmaceuticals, Inc. Common Stock | $4.7m | $1.51 | 0.0% | 7.6K |
 SBFM | Sunshine Biopharma Inc. | $4.5m | $1.89 | -1.1% | 37.4K |
 PHGE | BiomX Inc. | $4.1m | $0.19 | -6.5% | 827.6K |
 ITRM | Iterum Therapeutics plc Ordinary Share | $3.8m | $0.03 | +5.0% | 43.6M |
 VRAX | Virax Biolabs Group Limited Ordinary Shares | $2.3m | $3.77 | -2.1% | 390.5K |
 AEMD | AETHLON MEDICAL INC | $2.0m | $0.63 | -0.0% | 71.8K |